Published in Chest on February 01, 1996
Sleep abnormalities and treatment in emphysema. Proc Am Thorac Soc (2008) 1.03
Association of chronic obstructive pulmonary disease and obstructive sleep apnea consequences. Int J Chron Obstruct Pulmon Dis (2008) 0.96
Sleep-disordered breathing and COPD: the overlap syndrome. Respir Care (2010) 0.94
Update on obstructive sleep apnea and its relation to COPD. Int J Chron Obstruct Pulmon Dis (2014) 0.84
Obstructive sleep apnea and cardiovascular risk. Ther Clin Risk Manag (2007) 0.83
Diagnostic and therapeutic approach to coexistent chronic obstructive pulmonary disease and obstructive sleep apnea. Int J Chron Obstruct Pulmon Dis (2008) 0.81
Chronic obstructive pulmonary disease and obstructive sleep apnoea-the overlap syndrome. J Thorac Dis (2016) 0.77
Sleep and Obstructive Lung Diseases. Sleep Med Clin (2008) 0.77
Sleep effects on breathing and respiratory diseases. Lung India (2009) 0.76
Factors responsible for poor sleep quality in patients with chronic obstructive pulmonary disease. BMC Pulm Med (2016) 0.75
Predictive value of clinical features for the obstructive sleep apnoea syndrome. Eur Respir J (1996) 1.91
Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease. N Engl J Med (1984) 1.88
Pathophysiology of obstructive sleep apnoea. Eur Respir J (1995) 1.85
Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J (2000) 1.80
Reversible hypercapnia in chronic obstructive pulmonary disease: a distinct pattern of respiratory failure with a favorable prognosis. Am J Med (1997) 1.76
Hypoxaemia during chest physiotherapy in patients with cystic fibrosis. Ir J Med Sci (1986) 1.74
Management of obstructive sleep apnea in Europe. Sleep Med (2010) 1.56
Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax (2009) 1.45
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J (2009) 1.43
Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest (2000) 1.35
Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis (1982) 1.18
Is sleep apnoea more common in North America? Lancet (1982) 1.14
Public health and medicolegal implications of sleep apnoea. Eur Respir J (2002) 1.14
Role of respiratory sleep disorders in the pathogenesis of nocturnal angina and arrhythmias. Postgrad Med J (1994) 1.11
Inspiratory flow limitation during sleep in pre-eclampsia: comparison with normal pregnant and nonpregnant women. Eur Respir J (2001) 1.10
Bed partners' assessment of nasal continuous positive airway pressure therapy in obstructive sleep apnea. Chest (1997) 1.01
Effects of positive airway pressure on upper airway dilator muscle activity and ventilatory timing. J Appl Physiol (1985) (1996) 1.00
Acute stridor due to an upper tracheal membrane following endotracheal intubation. Eur Respir J (1999) 1.00
The nose and OSA: variable nasal obstruction may be more important in pathophysiology than fixed obstruction. Eur Respir J (2008) 0.99
Nocturnal deaths among patients with chronic bronchitis and emphysema. Br Med J (Clin Res Ed) (1984) 0.99
Subjective efficacy of nasal CPAP therapy in obstructive sleep apnoea syndrome: a prospective controlled study. Eur Respir J (1999) 0.98
Reflex respiratory response to changes in upper airway pressure in the anaesthetized rat. J Physiol (2001) 0.97
Obstructive sleep apnea following topical oropharyngeal anesthesia in loud snorers. Am Rev Respir Dis (1991) 0.97
Controlled oxygen therapy and carbon dioxide retention during exacerbations of chronic obstructive pulmonary disease. Lancet (2001) 0.97
Theophylline improves gas exchange during rest, exercise, and sleep in severe chronic obstructive pulmonary disease. Am Rev Respir Dis (1993) 0.96
Haemodynamic effects of nasal continuous positive airway pressure in severe congestive heart failure. Eur Respir J (1995) 0.94
Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. Thorax (2004) 0.93
A one-year prospective audit of an asthma education programme in an out-patient setting. Ir Med J (1997) 0.92
Adipose tissue in obesity and obstructive sleep apnoea. Eur Respir J (2011) 0.91
Ventilation and gas exchange during sleep in patients with interstitial lung disease. Thorax (1986) 0.91
Theophylline in obstructive sleep apnea. A double-blind evaluation. Chest (1992) 0.90
Comparison of three auto-adjusting positive pressure devices in patients with sleep apnoea. Eur Respir J (2006) 0.89
Beneficial effect of oxygen in primary alveolar hypoventilation with central sleep apnea. Am Rev Respir Dis (1982) 0.88
Comparison of a limited computerized diagnostic system (ResCare Autoset) with polysomnography in the diagnosis of obstructive sleep apnoea syndrome. Eur Respir J (1996) 0.85
Abnormal respiratory pattern generation during sleep in patients with autonomic dysfunction. Am Rev Respir Dis (1983) 0.85
Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Postgrad Med J (2009) 0.85
Compliance at night with low flow oxygen therapy: a comparison of nasal cannulae and Venturi face masks. Thorax (1995) 0.84
Honeycomb cysts in idiopathic pulmonary haemosiderosis: high-resolution CT appearances in two adults. Br J Radiol (2008) 0.84
Diagnostic criteria for the sleep apnoea syndrome: time for consensus. Eur Respir J (1996) 0.84
Comparison of oxygen desaturation during sleep and exercise in patients with cystic fibrosis. Chest (1991) 0.84
Upper airway obstruction during sleep in normal subjects after selective topical oropharyngeal anesthesia. Am Rev Respir Dis (1987) 0.83
Clinical and physiologic heterogeneity of the central sleep apnea syndrome. Am Rev Respir Dis (1986) 0.82
Late-onset central hypoventilation syndrome: a family genetic study. Eur Respir J (2007) 0.82
Efficacy of nasal continuous positive airway pressure therapy in chronic heart failure: importance of underlying cardiac rhythm. Thorax (1998) 0.82
Sarcoidosis presenting as upper extremity venous thrombosis. Thorax (2003) 0.82
Sleep-related breathing disorders: definitions and measurements. Eur Respir J (2000) 0.81
Portable monitoring in sleep apnoea: the way forward? Eur Respir J (2011) 0.81
Towards automated sleep state estimation using a Holter-oximeter. Conf Proc IEEE Eng Med Biol Soc (2007) 0.80
Treatment of Robin sequence with nasal CPAP. J Laryngol Otol (1995) 0.80
Reversible hypercapnia in acute exacerbations of chronic obstructive pulmonary disease (COPD). Eur Respir J (1993) 0.80
Impaired detection of added inspiratory resistance in patients with obstructive sleep apnea. Am Rev Respir Dis (1984) 0.80
Topical oropharyngeal anesthesia in patients with obstructive sleep apnea. Am J Respir Crit Care Med (1995) 0.79
Upper lobe bronchiectasis in the yellow nail syndrome: report of a case. Ir J Med Sci (1984) 0.79
Compliance with nasal CPAP therapy for obstructive sleep apnoea: how much is enough? Eur Respir J (1997) 0.79
Paradoxical vocal cord motion causing stridor after thyroidectomy. Thorax (2000) 0.78
Comparison of nebulized and sprayed topical anaesthesia for fibreoptic bronchoscopy. Eur Respir J (1992) 0.78
Clinical prediction of the sleep apnea syndrome. Sleep Med Rev (1997) 0.77
Resolution of obstructive sleep apnoea with growth in the Robin sequence. Eur Respir J (1998) 0.77
Oxygen desaturation during sleep and exercise in patients with severe chronic obstructive pulmonary disease. Respir Med (1995) 0.76
Arousal in the sleep apnoea syndrome: a mixed blessing? Eur Respir J (1998) 0.75
An unusual cause of orthopnoea. Postgrad Med J (1996) 0.75
Malignant chondroid syringoma presenting as multiple pulmonary nodules. Thorax (1997) 0.75
Effect of obesity in patients with coronary artery disease. Lancet (2006) 0.75
Continuous non-invasive monitoring of evolving acute severe asthma during sleep. Thorax (1994) 0.75
Sleepiness, sleep apnoea and driving risk. Ir Med J (2001) 0.75
Multifactorial hypokalaemia in a beer drinker. Ir J Med Sci (1993) 0.75
Sleep apnoea and driving risk. European Respiratory Society Task Force on "Public Health and Medicolegal Implications of Sleep Apnoea". Eur Respir J (1999) 0.75
Home mechanical ventilation. Ir Med J (2005) 0.75
Improved ventilatory function associated with relief of chest pain in a patient with Kartagener's syndrome treated by subcutaneous analgesia. Respir Med (2004) 0.75
Broncholithiasis: bronchoscopic vs. surgical management. Respir Med (1990) 0.75
The genetic and cardiovascular aspects of obstructive sleep apnoea/hypopnoea syndrome. Eur Respir J (2009) 0.75
Sleep and medical disorders. Ir Med J (1994) 0.75
Pulmonary fibrosis in polymyositis with the Jo-1 syndrome: an unusual mode of presentation. Respir Med (1998) 0.75
Sleep apnoea in the British Isles. Lancet (1986) 0.75
Nocturnal nasal intermittent positive pressure ventilation (NIPPV) therapy for chronic respiratory failure: long-term effects. Ir Med J (2000) 0.75
Controlling passive smoking through legislation in Ireland: an attack on civil liberty or good public health policy? Eur Respir J (2004) 0.75
The effects of atropine and glycopyrrolate on heart rates in conscious mature goats. Vet Surg (1996) 0.75
Chronic respiratory failure--evolving concepts. Ir J Med Sci (1988) 0.75
Educating the patient with asthma. Ir J Med Sci (1989) 0.75
A rapid desktop theophylline assay. Evaluation of use in clinical management. Chest (1997) 0.75
Sleep apnoea: a two-year experience. Ir Med J (1988) 0.75
Potassium and ventilation during exercise above and below the ventilatory threshold. Respir Physiol (1997) 0.75
Sleep HERMES: a European training project for respiratory sleep medicine. Eur Respir J (2011) 0.75